{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:21:59Z","timestamp":1783106519633,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier","isbn-type":[{"value":"9780443432248","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI155716"],"award-info":[{"award-number":["R01AI155716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.mie.2026.05.002","type":"book-chapter","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:47:33Z","timestamp":1779709653000},"page":"485-501","source":"Crossref","is-referenced-by-count":0,"title":["Site-specific antibody labeling via endo-S2 mediated Fc glycan remodeling"],"prefix":"10.1016","author":[{"given":"D. Natasha","family":"Owitipana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.mie.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody\u2013drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"6","key":"10.1016\/bs.mie.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/molecules28062605","article-title":"Antibody\u2013biopolymer conjugates in oncology: A review","volume":"28","author":"Chavda","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2297450","article-title":"Antibodies to watch in 2024","volume":"16","author":"Crescioli","year":"2024","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/bs.mie.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/abt\/tbaf010","article-title":"A review of conjugation technologies for antibody drug conjugates","volume":"8","author":"Fan","year":"2025","journal-title":"Antibody Therapeutics"},{"issue":"17","key":"10.1016\/bs.mie.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1074\/jbc.M116.721597","article-title":"Endo-F3 glycosynthase mutants enable chemoenzymatic synthesis of core-fucosylated triantennary complex type glycopeptides and glycoproteins","volume":"291","author":"Giddens","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","article-title":"Considerations for the design of antibody-based therapeutics","volume":"109","author":"Goulet","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","article-title":"The increasingly human and profitable monoclonal antibody market","volume":"37","author":"Grilo","year":"2019","journal-title":"Trends in Biotechnology"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acs.jmedchem.2c01791","article-title":"Degrader-antibody conjugates: Emerging new modality","volume":"66","author":"Hong","year":"2023","journal-title":"Journal of Medicinal Chemistry"},{"issue":"29","key":"10.1016\/bs.mie.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1021\/ja3051266","article-title":"Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions","volume":"134","author":"Huang","year":"2012","journal-title":"Journal of American Chemical Society"},{"issue":"10","key":"10.1016\/bs.mie.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cbic.201000242","article-title":"Arthrobacter Endo-\u03b2-N-acetylglucosaminidase shows transglycosylation activity on complex-type N-glycan oxazolines: One-pot conversion of ribonuclease B to sialylated ribonuclease C","volume":"11","author":"Huang","year":"2010","journal-title":"Chembiochem: a European Journal of Chemical Biology"},{"issue":"2","key":"10.1016\/bs.mie.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1874471011306020001","article-title":"Radionuclide antibody-conjugates, a targeted therapy towards cancer","volume":"6","author":"Kitson","year":"2013","journal-title":"Current Radiopharmaceuticals"},{"issue":"32","key":"10.1016\/bs.mie.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"16508","DOI":"10.1074\/jbc.M116.738765","article-title":"Glycosynthase mutants of endoglycosidase S2 show potent transglycosylation activity and remarkably relaxed substrate specificity for antibody glycosylation remodeling","volume":"291","author":"Li","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2026.05.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102420","article-title":"Recent advances in antibody glycoengineering for the gain of functions","volume":"78","author":"Liu","year":"2024","journal-title":"Current Opinion in Chemical Biology"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/bs.mie.2026.05.002_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310130","article-title":"Advances in research based on antibody-cell conjugation","volume":"14","author":"Ma","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/bs.mie.2026.05.002_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080872","article-title":"Advances and limitations of antibody drug conjugates for cancer","volume":"9","author":"McKertish","year":"2021","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/bs.mie.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/d41573-021-00079-7","article-title":"FDA approves 100th monoclonal antibody product","volume":"20","author":"Mullard","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"5","key":"10.1016\/bs.mie.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/jo8024708","article-title":"Efficient synthesis of sugar oxazolines from unprotected N-Acetyl-2-amino sugars by using chloroformamidinium reagent in water","volume":"74","author":"Noguchi","year":"2009","journal-title":"The Journal of Organic Chemistry"},{"issue":"12","key":"10.1016\/bs.mie.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1021\/acs.chemrev.2c00915","article-title":"The dawn of a new era: Targeting the \u201cUndruggables\u201d with antibody-based therapeutics","volume":"123","author":"Qian","year":"2023","journal-title":"Chemical Reviews"},{"issue":"20","key":"10.1016\/bs.mie.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","article-title":"Glycoconjugates: Synthesis, functional studies, and therapeutic developments","volume":"122","author":"Shivatare","year":"2022","journal-title":"Chemical Reviews"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20130126","article-title":"EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and \u03b11-acid glycoprotein","volume":"455","author":"Sj\u00f6gren","year":"2013","journal-title":"Biochemical Journal"},{"issue":"6, Part 1","key":"10.1016\/bs.mie.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biotechadv.2015.05.001","article-title":"Current methods for the synthesis of homogeneous antibody\u2013drug conjugates","volume":"33","author":"Sochaj","year":"2015","journal-title":"Biotechnology Advances"},{"issue":"8","key":"10.1016\/bs.mie.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/nprot.2017.058","article-title":"Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates","volume":"12","author":"Tang","year":"2017","journal-title":"Nature Protocols"},{"issue":"7","key":"10.1016\/bs.mie.2026.05.002_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bmc.2017.07.053","article-title":"One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes","volume":"26","author":"Tong","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.mie.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13238-016-0323-0","article-title":"Antibody-drug conjugates: Recent advances in conjugation and linker chemistries","volume":"9","author":"Tsuchikama","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/bs.mie.2026.05.002_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-biochem-062917-012911","article-title":"Glycoengineering of antibodies for modulating functions","volume":"88","author":"Wang","year":"2019","journal-title":"Annual Review of Biochemistry"},{"issue":"50","key":"10.1016\/bs.mie.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"17371","DOI":"10.1073\/pnas.0407965101","article-title":"Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG","volume":"101","author":"Wenig","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/bs.mie.2026.05.002_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500132","article-title":"Methods for the generation of single-payload antibody-drug conjugates","volume":"20","author":"Wharton","year":"2025","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/bs.mie.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acschembio.1c00597","article-title":"General and robust chemoenzymatic method for glycan-mediated site-specific labeling and conjugation of antibodies: Facile synthesis of homogeneous antibody\u2013Drug conjugates","volume":"16","author":"Zhang","year":"2021","journal-title":"ACS Chemical Biology"},{"issue":"6","key":"10.1016\/bs.mie.2026.05.002_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1021\/acs.bioconjchem.2c00142","article-title":"Synthesis and evaluation of three azide-modified disaccharide oxazolines as enzyme substrates for single-step Fc glycan-mediated antibody-drug conjugation","volume":"33","author":"Zhang","year":"2022","journal-title":"Bioconjugate Chemistry"}],"container-title":["Methods in Enzymology","Bioorthogonal Labeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687926001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687926001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:51:45Z","timestamp":1783104705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687926001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443432248"],"references-count":30,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2026.05.002","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}